{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:58:50Z","timestamp":1762271930179},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T00:00:00Z","timestamp":1438732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11307-015-0876-y","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T10:57:41Z","timestamp":1438685861000},"page":"201-208","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near-Infrared Fluorescent Imaging Agent"],"prefix":"10.1007","volume":"18","author":[{"given":"Lindsay E.","family":"Kelderhouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakkarapalayam","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,5]]},"reference":[{"key":"876_CR1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/rheumatology\/keh673","volume":"44","author":"AN Bennett","year":"2005","unstructured":"Bennett AN, Peterson P, Zain A et al (2005) Adalimumab in clinical practice: outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure. Rheumatology 44:1026\u20131031","journal-title":"Rheumatology"},{"key":"876_CR2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.autrev.2008.11.001","volume":"8","author":"C Bazzani","year":"2009","unstructured":"Bazzani C, Filippini M, Caporali R et al (2009) Anti-TNF \u03b1 therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. Autoimmun Rev 8:260\u2013265","journal-title":"Autoimmun Rev"},{"key":"876_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10067-004-0869-8","volume":"24","author":"R Rau","year":"2005","unstructured":"Rau R (2005) Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents. Clin Rheumatol 24:189\u2013202","journal-title":"Clin Rheumatol"},{"issue":"Suppl 1","key":"876_CR4","first-page":"S25","volume":"65","author":"Y Yazici","year":"2007","unstructured":"Yazici Y (2007) Monitoring response to treatment in rheumatoid arthritis. Which tool is best suited for routine \u201creal world\u201d care? Bull NYU Hosp Jt Dis 65(Suppl 1):S25\u2013S28","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"876_CR5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/ard.62.7.597","volume":"62","author":"PA Ory","year":"2003","unstructured":"Ory PA (2003) Interpreting radiographic data in rheumatoid arthritis. Ann Rheum Dis 62:597\u2013604","journal-title":"Ann Rheum Dis"},{"key":"876_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar794","volume":"5","author":"PC Taylor","year":"2003","unstructured":"Taylor PC (2003) The value of sensitive imaging modalities in rheumatoid arthritis. Arthritis Res Ther 5:210\u2013213","journal-title":"Arthritis Res Ther"},{"key":"876_CR7","unstructured":"(1996) American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 37:713\u2013722"},{"key":"876_CR8","doi-asserted-by":"crossref","first-page":"ii41","DOI":"10.1093\/rheumatology\/keg332","volume":"42","author":"FC Breedveld","year":"2003","unstructured":"Breedveld FC (2003) Should rheumatoid arthritis be treated conservatively or aggressively? Rheumatology 42:ii41\u2013ii43","journal-title":"Rheumatology"},{"key":"876_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9343(01)00872-5","volume":"111","author":"LR Lard","year":"2001","unstructured":"Lard LR, Visser H, Speyer I et al (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111:446\u2013451","journal-title":"Am J Med"},{"key":"876_CR10","first-page":"623","volume":"27","author":"E Tsakonas","year":"2000","unstructured":"Tsakonas E, Fitzgerald AA, Fitzcharle MA (2000) Consequences of delayed therapy with second line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 27:623\u2013629","journal-title":"J Rheumatol"},{"key":"876_CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cbpa.2009.10.022","volume":"14","author":"JO Escobedo","year":"2010","unstructured":"Escobedo JO, Rusin O, Lim S (2010) Strongin RM (2010) NIR dyes for bioimaging applications. Curr Opin Chem Biol 14:64","journal-title":"Curr Opin Chem Biol"},{"key":"876_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2325\/jbcs.12.211","volume":"12","author":"T Kitai","year":"2005","unstructured":"Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211\u2013215","journal-title":"Breast Cancer"},{"issue":"65","key":"876_CR13","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/art.38175","volume":"2013","author":"SG Werner","year":"2013","unstructured":"Werner SG, Langer HE, Schott P et al (2013) Backhaus M: indocyanine green-enhanced fluorescence optical imaging in patients with early and very early arthritis: a comparative study with magnetic resonance imaging. Arthritis Rheum 2013(65):3036\u20133044","journal-title":"Arthritis Rheum"},{"key":"876_CR14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/annrheumdis-2010-148288","volume":"71","author":"SG Werner","year":"2012","unstructured":"Werner SG, Langer HE, Ohrndorf S et al (2012) Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology. Ann Rheum Dis 71:504\u2013510","journal-title":"Ann Rheum Dis"},{"key":"876_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/jsre.2001.6328","volume":"103","author":"O Okochi","year":"2002","unstructured":"Okochi O, Kaneko T, Sugimoto H et al (2002) ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 103:109\u2013113","journal-title":"J Surg Res"},{"key":"876_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jtcvs.2008.09.082","volume":"138","author":"E Tanaka","year":"2009","unstructured":"Tanaka E, Chen FY, Flaumenhaft R et al (2009) Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 138:133\u2013140","journal-title":"J Thorac Cardiovasc Surg"},{"key":"876_CR17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0161-6420(98)96008-0","volume":"105","author":"AA Chang","year":"1998","unstructured":"Chang AA, Morse LS, Handa JT et al (1998) Histologic localization of indocyanine green dye in aging primate and human ocular tissues with clinical angiographic correlation. Ophthalmology 105:1060\u20131068","journal-title":"Ophthalmology"},{"key":"876_CR18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L","volume":"42","author":"N Nakashima-Matsushita","year":"1999","unstructured":"Nakashima-Matsushita N, Homma T, Yu S (1999) Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 42:1609\u20131616","journal-title":"Arthritis Rheum"},{"key":"876_CR19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood-2008-04-150789","volume":"113","author":"W Xia","year":"2009","unstructured":"Xia W, Hilgenbrink AR, Matteson EL et al (2009) A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113:438\u2013446","journal-title":"Blood"},{"key":"876_CR20","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar1944","volume":"8","author":"CM Paulos","year":"2006","unstructured":"Paulos CM, Varghese B, Widmer WR et al (2006) Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther 8:R77","journal-title":"Arthritis Res Ther"},{"key":"876_CR21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2967\/jnumed.111.099390","volume":"53","author":"B Vaitilingam","year":"2012","unstructured":"Vaitilingam B, Chelvam V, Kularatne SA et al (2012) A folate receptor-\u03b1-specific ligand that targets cancer tissue and not sites of inflammation. J Nucl Med 53:1127\u20131134","journal-title":"J Nucl Med"},{"key":"876_CR22","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/art.10405","volume":"46","author":"MJ Turk","year":"2002","unstructured":"Turk MJ, Breur GJ, Widmer WR et al (2002) Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 46:1947\u20131955","journal-title":"Arthritis Rheum"},{"key":"876_CR23","first-page":"253","volume":"27","author":"EL Matteson","year":"2009","unstructured":"Matteson EL, Lowe VJ, Prendergast FG (2009) Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol 27:253\u2013259","journal-title":"Clin Exp Rheumatol"},{"issue":"53","key":"876_CR24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2967\/jnumed.111.099671","volume":"2012","author":"NA Jager","year":"2012","unstructured":"Jager NA, Westra J, van Dam GM (2012) Targeted folate receptor \u03b2 fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque. J Nucl Med 2012(53):1222\u20131229","journal-title":"J Nucl Med"},{"key":"876_CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-8417-3_9","volume-title":"Targeted drug strategies for cancer and inflammation","author":"MJ Hansen","year":"2011","unstructured":"Hansen MJ, Low PS (2011) Folate receptor positive macrophages: cellular targets for imaging and therapy of inflammatory and autoimmune diseases. In: Jackman AL, Leamon CP (eds) Targeted drug strategies for cancer and inflammation. Springer, New York, pp 181\u2013193"},{"key":"876_CR26","unstructured":"Mahalingam SM, Kularatne SA, Roy J, Low PS (2013) Evaluation of pteroyl-amino acid-NIR dye conjugates for tumor targeted fluorescence guided surgery. [abstract]. Papers of the American Chemical Society 246 MEDI 329"},{"key":"876_CR27","unstructured":"Gagare PD, Noshi M, Myers C, Kularatne SA, Low PS: OTL-0038 (2013) A potent folate receptor (FR)-targeted NIR dye. [abstract]. Papers of the American Chemical Society 246 MEDI 328"},{"key":"876_CR28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2:1269\u20131275","journal-title":"Nat Protoc"},{"key":"876_CR29","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2319","volume":"9","author":"JJ Inglis","year":"2007","unstructured":"Inglis JJ, Criado G, Medghalchi M (2007) Collagen-induced arthritis in C57BL\/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther 9:R113","journal-title":"Arthritis Res Ther"},{"key":"876_CR30","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/eji.1830261008","volume":"26","author":"LM Webb","year":"1996","unstructured":"Webb LM, Walmsley MJ, Feldmann M (1996) Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 26:2320\u20132328","journal-title":"Eur J Immunol"},{"key":"876_CR31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:541\u2013546","journal-title":"Nat Protoc"},{"key":"876_CR32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(83)90008-0","volume":"88","author":"JA Smith","year":"1983","unstructured":"Smith JA (1983) The effect of atropine, cimetidine and FPL 52694 on duodenal ulcers in mice. Eur J Pharmacol 88:215\u2013221","journal-title":"Eur J Pharmacol"},{"key":"876_CR33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2036.1998.00357.x","volume":"12","author":"LG Axelsson","year":"1998","unstructured":"Axelsson LG, Landstrom E, Bylund-Fellenius AC (1998) Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther 12:925\u2013934","journal-title":"Aliment Pharmacol Ther"},{"key":"876_CR34","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","volume":"27","author":"S Zadelaar","year":"2007","unstructured":"Zadelaar S, Kleemann R, Verschuren L et al (2007) Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27:1706\u20131721","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"876_CR35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/adip.21837","volume":"2","author":"M Iwashita","year":"2013","unstructured":"Iwashita M, Nakatsu Y, Sakoda H et al (2013) Valsartan restores inflammatory response by macrophages in adipose and hepatic tissues of LPS-infused mice. Adipocyte 2:28\u201332","journal-title":"Adipocyte"},{"key":"876_CR36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.HYP.0000145179.44166.0f","volume":"44","author":"Z Li","year":"2004","unstructured":"Li Z, Iwai M, Wu L et al (2004) Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension 44:758\u2013763","journal-title":"Hypertension"},{"key":"876_CR37","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","volume":"294","author":"BB Moore","year":"2008","unstructured":"Moore BB, Hogaboam CM (2008) Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L152\u2013160","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"876_CR38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, Ask K, Warburton D et al (2008) The bleomycin animal model; a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40:362\u2013382","journal-title":"Int J Biochem Cell Biol"},{"key":"876_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/ar86","volume":"2","author":"RW Kinne","year":"2000","unstructured":"Kinne RW, Br\u00e4uer R, Stuhlm\u00fcller B et al (2000) Macrophages in rheumatoid arthritis. Arthritis Res 2:189\u2013202","journal-title":"Arthritis Res"},{"key":"876_CR40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1053\/j.gastro.2009.12.041","volume":"138","author":"MM Hunter","year":"2010","unstructured":"Hunter MM, Wang A, Parhar KS et al (2010) In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138:1395\u20131405","journal-title":"Gastroenterology"},{"key":"876_CR41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","volume":"137","author":"DV Pechkovsky","year":"2010","unstructured":"Pechkovsky DV, Prasse A, Kollert F et al (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 137:89\u2013101","journal-title":"Clin Immunol"},{"key":"876_CR42","doi-asserted-by":"crossref","first-page":"R310","DOI":"10.1186\/ar1483","volume":"7","author":"WT Chen","year":"2005","unstructured":"Chen WT, Mahmood U, Weissleder R, Tung CH (2005) Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 7:R310\u2013R317","journal-title":"Arthritis Res Ther"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-015-0876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-015-0876-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-015-0876-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T09:36:35Z","timestamp":1559381795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-015-0876-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1007\/s11307-015-0876-y","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,5]]}}}